Y-mAbs resubmits U.S. marketing application for omburtamab to FDA
April 01 2022 - 9:47AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Y mAbs Therapeutics (NASDAQ:YMAB)
Historical Stock Chart
From Aug 2024 to Sep 2024
Y mAbs Therapeutics (NASDAQ:YMAB)
Historical Stock Chart
From Sep 2023 to Sep 2024